
The Power of
Persuasion: Gaining Insight into
Market
Intelligence and Influencers
By Co-Founders
Bonnie Rishell, CEO and
Archie Anderson,
Vice President
ROI2
Are you looking to:
• Enter the market with a new product—but don’t
understand the market?
• Expand your market share in an existing
market – but see signs of weakening market
share
and need new data sets to be more competitive?
• Roll out a new indication for existing
product?
• Reach a new audience for your current
product?
• Reposition your product in light of new
market shifts, waning market share or
competitors
on the horizon?
ROI2 can help.
In the world of marketing and
medical education, getting your marketing
strategy right–the first time–can spell the
difference between success and failure. With
more factors involved in the decision-making
process, increased competition, greater
sophistication in parsing market intelligence,
and more at stake than ever before, companies
are looking for new ways to leverage their data
to increase their chances of recognition,
acceptance, uptake and utilization.
Marketing success
today depends on the ability to identify,
extract, analyze and synthesize business
intelligence. Prolink, ROI2’s
parent company, has years of experience in
providing business intelligence solutions to
leading corporations in finance, communications
and media. Recognizing the value of these
intelligence tools to pharmaceutical companies,
ROI2
was created to help pharmaceutical companies
gather, analyze and utilize data to pinpoint
their messages, marketing initiatives and brand
strategies. By combining the company’s
innovative technology and ability to capture
business intelligence with pharmaceutical
marketing expertise, ROI2
has developed a proprietary platform that allows
pharmaceutical companies to increase the
likelihood of brand adoption and success.
Offering a wide range
of services—including consultation, product and
market analysis, market and brand strategy
evaluation, KOL Identification and influence
mapping—ROI2
delivers business intelligence unmatched by any
other company today. Our board includes experts
in all areas of the field: highly respected
physicians, industry analysts, senior executives
in pharmaceutical companies, FDA and other
governmental advisors. Working with you every
step of the way, these specialists help us bring
you the data needed by every member of your
team, from product and brand management through
the marketing and sales sides. We help analyze
your product, competition, target audiences,
position and market strategies, and understand
the factors—and people—who influence brand
adoption. Starting with the basics, we look at:
Where are you in the market—pre- or post-launch,
for example—and what kinds of data sets you
need? Who do you need to reach? Who and where
are they? Using analytics and surveys to gain
insights into the right influencers, we help
determine your positioning, sales and influence
strategies.
Recognizing that gaining insight into the
dynamics of influence networks is likely to have
a measurable impact on product adoption, ROI2
develops intelligence about the anatomy of
individual influence networks, providing
insights that support marketing and sales
management efforts to generate brand adoption
within key target audiences. Such information
includes identification of the thought leaders
you need to reach, particularly at the regional
and local level; how they compare with others in
the field; who are the most respected authors,
speakers, clinical investigators in the
category—by region; what institutions are they
affiliated with—and which institutions are most
respected? What are their preferred treatment
protocols? How do they like to get their
information—through medical journals, medical
education meetings, presentations or sales
reps?
And we don’t stop there. We look
at trends. Past data sets. Key factors that
drive influence and promote brand adoption. And
much more.
KOL Identification
and Influence Mapping
ROI2
uses three approaches to identify peer-selected
opinion leaders and the networks of physicians
they influence: the bottom-up method, the
top-down method, and profiling. The bottom-up
method involves surveying a large sample of
high-prescriber target physicians and looking
for clear patterns that suggest leadership
within a given network. Generally, when specific
physicians are identified over and over as a key
influential force, they emerge as thought
leaders. The top-down approach involves
searching the medical literature to identify top
authors, surveying them, and essentially coming
up with “the top of the top.” Finally, profiling
provides a constantly updated reference to the
leading KOLs that includes their participation
in medical journals, clinical trials, events,
medical associations, medical education,
scientific contributions, pharmaceutical company
relationships and more.
The value of influence data lies
in its precision. Our maps, for example, clearly
show that within any influence network, multiple
centers of gravity and webs of meaningful
interconnectedness exist. Once you understands
the macro- and micro-dynamics of an influence
network, you can utilize KOL influence
strategically, on national, regional, and local
levels, at scientific and dinner meetings, for a
range of research initiatives and publishing
plans.
To gather the most
relevant and appropriate intelligence for your
particular product and needs, ROI2’s
specialists take you through carefully
delineated steps. This kind of planning is
critical in obtaining successful and usable
results. First, we meet with all stake-holders
involved with the particular product. Our goal:
to determine the objectives, along with the
intelligence and insights you (i.e., all members
of the brand team) need, to accomplish your
goals. Second, we distribute a target list of
physicians across your company’s sales
organization to ensure that it includes
physicians in every region, district,
Metropolitan Statistical Area (MSA),
and territory, so that every unit
of the organization will be able to identify
specific KOLs who can provide a range of
services for their needs. Third, we develop a
survey based on your objectives, mail it to our
target physicians, and analyze and integrate our
findings into a customizable database.
In conjunction with
standard business intelligence analytics, our
peer-nomination-based surveys yield information
that allows analysts to construct models of
influence networks that map the complex
interrelationships within a large network of
opinion leaders. These networks are
multidimensional, not only reflecting influence
within a specific therapeutic area, but more
strategically, homing in on specific issues
within that therapeutic area and identifying
KOLs based on their influence within a very
discrete category. This process of drilling down
to access granular details is extended to
institutions, professional associations, and
association guidelines.
Once we have completed our intelligence
gathering, we then gather all data, incorporate
them into our database, create maps and other
analytic tools and upload the information to our
website for client use. This information can be
easily accessed via the Web in a wide variety of
customized formats and updated in real time
through streaming competitive intelligence
programs that include authorships, clinical
trials, profiling and the like.
ROI2’s
Medical Intelligence Portal is one of our key
advantages. Built on a .Net platform, it allows
clients to easily import and export key
information—including IMS Rx data —to and from
other data sites within the company. Such data
allows ROI2
to go far beyond the traditional analysis and
determine not just the selection ranking or
leaders but also the market value of the
leaders.
This portal gives
clients the ability to access new data,
integrate it into an existing database or SFA
application, access the combined data and
generate customized reports at will.
User-friendly and interactive, the ROI2
Web platform can push information out to client
data centers and integrate information from the
clients’ staff and sales force, keeping all data
up to the minute and providing more detailed
views of influence relationships.
What’s more, with all data in one
place, people at every level of your
organization—from product marketing to research,
sales to management—
can access data that’s customized
for their individual use. This allows them to
“dice and slice” the data in a multitude of ways
for a variety of purposes, then download and
print it out with charts and graphs. Each person
can log in and get what he or she needs with a
password and the click of a mouse.
As the process of business
intelligence and influence mapping has become
more sophisticated and refined, the potential
for using influence data to increase brand
awareness and uptake has increased. Companies
can use the data to develop programs that
communicate its product’s position to opinion
leaders; recruit opinion leaders as advocates
for speaker programs; and use national opinion
leaders within local influence groups. They can
also identify KOLs as either national or local
leaders, early adopters, rising stars, or
referral leaders and recruit them based on those
identities. They may be invited, for example, to
participate in a variety of activities,
including take part in clinical research
studies, author articles in high-profile medical
journals, join advisory boards and speak at a
key medical meeting.
Intelligence like
this is a key part of every marketing and sales
activity surrounding a product. These activities
include: selecting speakers—down to the
territory; targeting early adopter KOLs,
identifying advocates at community hospitals for
formulary acceptance, segmenting leaders by key
issues, identifying high value sales targets,
developing medical journal plans, medical
association programs, dinner meetings, and more.
Possibilities become more
exciting when data makes it possible to match
KOLs very closely with target audiences. For
example, if Dr. Jones, a renowned KOL specialist
who performs CABG procedures, is also recognized
as a leading expert in blood conservation, a
company can organize a meeting featuring Dr.
Jones as a speaker, inviting target physicians
who are especially interested in blood
conservation. This kind of scenario has been
customized and used by our clients to focus in
on the specific types of influence drive their
business.
Beyond matching KOLs and specific
target audiences, influence data is also useful
for increasing sales force effectiveness,
identifying potential advocates at hospitals for
formulary efforts, and targeting research
centers and cultivating relationships with
researchers for continuing product development.
By integrating such information into other
marketing data, it can create a powerful
marketing tool with remarkable breadth and
depth, helping clients not only generate loyalty
among key physicians but also maintain that
loyalty, in spite of competitors’ communication
efforts.
The
bottom line: Getting your marketing and brand
strategy right starts with business intelligence
that captures exactly what you need, when and
how you need it. Teamed with the right partner,
you can cut costs, impact thought leaders,
shorten the time needed for product uptake,
influence patient treatment and gain a vital
advantage in the marketplace. That partner: ROI2.
Back
to Main Homepage
Return
to Top
|